HomeCTABF • OTCMKTS
add
Canntab Therapeutics Ord Shs
Previous close
$0.00
Market cap
194.45K CAD
Avg Volume
167.00
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | 2022info | Y/Y change |
|---|---|---|
Revenue | 293.36K | — |
Operating expense | 3.67M | 10.09% |
Net income | -3.69M | 16.53% |
Net profit margin | -1.26K | — |
Earnings per share | — | — |
EBITDA | -4.11M | -31.25% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | 2022info | Y/Y change |
|---|---|---|
Cash and short-term investments | 691.11K | -53.64% |
Total assets | 2.85M | -55.16% |
Total liabilities | 3.16M | -22.70% |
Total equity | -311.22K | — |
Shares outstanding | 38.91M | — |
Price to book | -0.00 | — |
Return on assets | -62.49% | — |
Return on capital | -107.34% | — |
Cash Flow
Net change in cash
| (CAD) | 2022info | Y/Y change |
|---|---|---|
Net income | -3.69M | 16.53% |
Cash from operations | -2.85M | 0.13% |
Cash from investing | 151.35K | 143.86% |
Cash from financing | 1.89M | -26.98% |
Net change in cash | -799.75K | -33.39% |
Free cash flow | -1.36M | 31.66% |
About
Founded
2010
Headquarters
Website
